Table 2. Oncological treatment given before and after PDT.
| All | Female | Male | |
|---|---|---|---|
| No prior treatment |
7 |
1 |
6 |
| Prior chemotherapy |
3 |
0 |
3 |
| Prior chemo-radiotherapy |
3 |
1 |
2a |
| Prior immunotherapy |
2b |
2 |
0 |
| No treatment after PDT |
3 |
1 |
2 |
| Chemotherapy after PDT |
8 |
2 |
6 |
| Chemo-radiotherapy after PDT |
1 |
0 |
1 |
| Immunotherapy after PDT |
2b |
1 |
1 |
| Whipple's pancreaticoduodenectomy+chemotherapy after PDT | 1 | 0 | 1 |
Abbreviation: PDT=photodynamic therapy.
a
One patient was previously enrolled in the PACER Trial (Radical radiotherapy with concurrent Cetuximab monoclonal antibody therapy).
b
Four patients were enrolled in the Telovac Trial (GV1001 vaccine vs gemcitabine+capecitabine in a phase III trial for advanced and metastatic pancreatic cancer). No oncological treatment was given less than a month before or after PDT .